What Strategy Should France Implement for H2020? - 08/07/16
, François Bassompierre 1, Christophe Misse 1, Vincent Diebolt 3, ** , Brigitte Pouletty-Lefèbvre 4, *** , the participants of round table N°6 at Giens XXX:
Angela Baker 5, Thomas Borel 6, David Braunstein 7, Jacques Demotes 8, Bruno François 9, Stéphane Huet 10, Joëlle Micallef 11, Annamaria Molon 12, Olivier Rascol 13, Sophie Ravoire 14, Bertrand Schwartz 15,contributions through interviews with
Nathalie Donne 16, Guillaume Fusaï 17, Philippe Pouletty 18, Eric Vicaut 19, †Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
The initiation of Horizon 2020—the European Union’s 8th Framework Programme for Research and Innovation, allotted a budget of 79 billion euros—provides an opportunity to review France’s participation in previous Framework Programmes. Indeed, French participation does not match either its scientific importance or its financial investment. While France contributed 16.5 to 17% of the EU’s 7th Framework Programme research budget, its return through the funding of coordinated projects in which French teams are participating stands at around 12.5 to 13%, a shortfall of 600 million euros. Although the situation depends on the type of activity, French participation in clinical research appears to be smaller than that of its neighbours, with fewer responses to European calls for proposals.
While France has many assets, which include the assured funding of clinical research, structured thematic networks and the initiation of major national programmes, it suffers from the dilution of resources due to France’s regional development policy, the lack of multidisciplinarity and the ignorance of both the medical and scientific community and the institutions to which they belong as to how Horizon 2020 actually works.
We propose three types of strategy to encourage proposals for coordinated clinical research projects or projects involving French teams, and to help in the drawing up of applications:
• | Broaden the vision of our children, students and colleagues, helping them to adapt to the globalisation of knowledge throughout their educational and professional lives. |
• | Recognise the value of European actions to influence the European landscape and change mentalities. |
• | Help and support project initiators by pooling skills within a limited number of expert centres designed to assist them in their funding application. |
Keywords : France, Europe, FP (Framework Programme), R&I (research and innovation), Horizon 2020, information, education, incentive, value, pooling
Abbreviations : ANR, ARIIS, AVIESAN, CHU, CNCR, COFUND, ERA-NET, ERC, ERDF, ESF, FP, IMI, PHC, PHRC, R&D, R&I, SME, SWOT
Plan
Vol 70 - N° 1
P. 103-109 - janvier 2015 Retour au numéro
Article précédent
- Quelle stratégie française dans le cadre H2020 ?
- Jean-François Dhainaut, François Bassompierre, Christophe Misse, Vincent Diebolt, Brigitte Pouletty-Lefèbvre, et les participants à la table ronde N°6 de Giens XXX :, Angela Baker, Thomas Borel, David Braunstein, Jacques Demotes, Bruno François, Stéphane Huet, Joëlle Micallef, Annamaria Molon, Olivier Rascol, Sophie Ravoire, Bertrand Schwartz, et avec la contribution sous forme d’audition, de Nathalie Donne, Guillaume Fusaï, Philippe Pouletty, Eric Vicaut
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?